|
CN111253304A
|
|
Preparation method of nifedipine
|
|
CN111233672A
|
|
Method for synthesizing nifedipine intermediate by using combined catalyst
|
|
CN110698410A
|
|
Preparation method of 2-n-propyl-4-methyl-6- (1' -methylbenzimidazole-2-yl) benzimidazole
|
|
CN110713463A
|
|
Preparation method of 2-n-propyl-4-methyl-6-carboxylic acid benzimidazole
|
|
CN110563635A
|
|
New method for micronizing raw material medicines of dihydropyridine antihypertensive drugs
|
|
CN109535017A
|
|
A kind of VENLAFAXINE HCL preparation method
|
|
CN109470798A
|
|
A kind of method of liquid chromatography for measuring alogliptin benzoate enantiomter
|
|
CN109694344A
|
|
The impurity and its preparation method and application that felodipine preparation process generates
|
|
CN111303130A
|
|
Doxazosin mesylate crystal form, and preparation method and application thereof
|
|
US2020283511A1
|
|
Protein binding to fibronectin b domain
|
|
CN109988158A
|
|
X crystal form, doxazosin mesylate containing X crystal form and its preparation method and application
|
|
CN107929253A
|
|
A kind of isosorbide mononitrate osmotic pump controlled release tablet and preparation method thereof
|
|
CN108046403A
|
|
A kind of processing method of sulfhydryl compound production waste liquid and its application
|
|
CN107628974A
|
|
A kind of dimercaptosuccinic acid and its salt and preparation method
|
|
CN107449844A
|
|
A kind of method for determining Succimer preparation dissolution rate
|
|
CN108430511A
|
|
A kind of drug and its application of drug design method and acquisition
|
|
CN106632548A
|
|
High-purity troxerutin and preparation method thereof
|
|
CN106349393A
|
|
Structure for enhancing antibody drug stability
|
|
CN106265537A
|
|
Sodium dimercaptopropanesulfonate freeze-dried powder and preparation method thereof
|
|
CN106336396A
|
|
Alogliptin benzoate preparation method
|
